P G Tardi - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

P G Tardi

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

Drug Safety|December 12, 2001

A comparison of liposomal formulations of doxorubicin with drug administered in free form: changing toxicity profilesD N Waterhouse, P G Tardi, L D Mayer, et al.

Journal of Immunological Methods|March 31, 1998

An immune response to ovalbumin covalently coupled to liposomes is prevented when the liposomes used contain doxorubicinP G Tardi, E N Swartz, T O Harasym, et al.

The Journal of Pharmacology and Experimental Therapeutics|December 1, 1995

Accumulation of protein-coated liposomes in an extravascular site: influence of increasing carrier circulation lifetimesS A Longman, P G Tardi, M J Parr, et al.

Methods in Molecular Medicine|February 15, 2011

Antibody conjugation methods for active targeting of liposomesS M Ansell, T O Harasym, P G Tardi, et al.

Pageof 2

Search research articles

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

Drug Safety|December 12, 2001

A comparison of liposomal formulations of doxorubicin with drug administered in free form: changing toxicity profilesD N Waterhouse, P G Tardi, L D Mayer, et al.

Journal of Immunological Methods|March 31, 1998

An immune response to ovalbumin covalently coupled to liposomes is prevented when the liposomes used contain doxorubicinP G Tardi, E N Swartz, T O Harasym, et al.

The Journal of Pharmacology and Experimental Therapeutics|December 1, 1995

Accumulation of protein-coated liposomes in an extravascular site: influence of increasing carrier circulation lifetimesS A Longman, P G Tardi, M J Parr, et al.

Methods in Molecular Medicine|February 15, 2011

Antibody conjugation methods for active targeting of liposomesS M Ansell, T O Harasym, P G Tardi, et al.

Pageof 2